{
    "code": "02025018",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025018",
    "time": "2019-06-28 03:04:10",
    "許可證字號": "衛署藥輸字第025018號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/04\/29",
    "發證日期": "98\/04\/29",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202501800",
    "中文品名": "米達紗賓",
    "英文品名": "Mirtazapine",
    "適應症": "鬱症。",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "01製劑原料",
    "主成分略述": "",
    "主製造廠": {
        "申請商名稱": "0618401100  百歐敏國際有限公司",
        "申請商地址": "台北市中山區中山北路三段３０號１１樓之１",
        "主製造廠": "",
        "製造廠名稱": "FIN0330100  MEGAFINE PHARMA (P) LTD."
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FIN1035000  MEGAFINE PHARMA (P) LTD.",
            "製造廠廠址": "SETHNA, 4TH FLOOR, 55 MAHARSHI KARVE ROAD, MARINE LINES, MUMBAI-400 002, INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": "製造廠公司"
        }
    ],
    "ingredients": []
}